In an ovarian cancer cell line (A2780), soluble Sema4D promoted angiogenesis and VM via plexin B1 (95); moreover, in clinical samples from patients, a high expression of Sema4D had a positive correlation with the malignant degree of epithelial ovarian cancer. Here, SEMA4D is linked to ovarian carcinoma.